BullFrog AI Holdings (BFRGW) Assets Average (2023 - 2026)
BullFrog AI Holdings' (BFRGW) quarterly Assets Average came in at $5.3 million in Q2 2026, up 51.0% on a YoY basis from $3.5 million in Q2 2025, and up 90.58% quarter-over-quarter from $2.8 million in Q4 2025.
Analysis
BullFrog AI Holdings (BFRGW) Assets Average (2023 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRGW) has reported Assets Average for 4 consecutive years, with $5.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average rose 51.0% year-over-year to $5.3 million; the trailing twelve-month figure through Jun 2026 stood at $5.3 million (up 51.0% YoY), and the FY2025 full-year result was $4.2 million, changed 0.38% from the prior year.
- Assets Average improved to $5.3 million in Q2 2026 per BFRGW's latest filing, from $2.8 million in the prior quarter.
- Across five years, Assets Average topped out at $6.9 million in Q2 2024 and bottomed at $2.8 million in Q4 2025.
- Historically, Assets Average has averaged $4.6 million across 4 years, with a median of $5.1 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Assets Average surged 65.13% in 2024, then tumbled 49.33% in 2025.
- Over 4 years, Assets Average stood at $3.5 million in 2023, then surged by 45.23% to $5.1 million in 2024, then sank by 45.73% to $2.8 million in 2025, then jumped by 90.58% to $5.3 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $5.3 million, $2.8 million, and $2.8 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.75 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 181.27 Bn | 178.09 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 132.28 Bn | 124.42 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 82.76 Bn | 74.77 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn | 11.22 Bn |
| 7 | Alnylam Pharmaceuticals | 33.96 Bn | 30.66 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 31.22 Bn | 29.93 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Roivant Sciences | 29.94 Bn | 29.94 Bn | 1.16 Mn | 5.51 Bn |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | 5.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.25 Mn |
| Dec 31, 2025 | 2.76 Mn |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 3.48 Mn |
| Mar 31, 2025 | 4.82 Mn |
| Dec 31, 2024 | 5.08 Mn |
| Sep 30, 2024 | 5.34 Mn |
| Jun 30, 2024 | 6.86 Mn |
| Mar 31, 2024 | 5.21 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Sep 30, 2023 | 5.13 Mn |
| Jun 30, 2023 | 6.14 Mn |
| Mar 31, 2023 | 3.16 Mn |